HealthStream, Inc. (NASDAQ:HSTM) Receives $32.00 Average Price Target from Brokerages

Shares of HealthStream, Inc. (NASDAQ:HSTM) have been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $32.00.

A number of research firms have recently commented on HSTM. JMP Securities reiterated a “market perform” rating on shares of HealthStream in a research report on Thursday, February 6th. Canaccord Genuity Group increased their price objective on shares of HealthStream from $29.00 to $30.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Finally, William Blair restated an “outperform” rating on shares of HealthStream in a report on Tuesday, February 25th.

HealthStream Stock Down 1.7 %

Shares of HSTM stock opened at $31.89 on Friday. The stock has a market cap of $970.54 million, a P/E ratio of 49.06, a PEG ratio of 4.37 and a beta of 0.37. The company’s fifty day simple moving average is $32.61 and its two-hundred day simple moving average is $31.45. HealthStream has a 52 week low of $23.92 and a 52 week high of $34.24.

HealthStream (NASDAQ:HSTM) last posted its earnings results on Monday, February 24th. The technology company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03. The company had revenue of $74.24 million for the quarter, compared to the consensus estimate of $73.55 million. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. During the same period in the previous year, the business earned $0.14 earnings per share. On average, analysts anticipate that HealthStream will post 0.63 EPS for the current fiscal year.

HealthStream Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Monday, March 10th were issued a dividend of $0.031 per share. This represents a $0.12 annualized dividend and a yield of 0.39%. The ex-dividend date was Monday, March 10th. This is a positive change from HealthStream’s previous quarterly dividend of $0.03. HealthStream’s dividend payout ratio is presently 18.18%.

Institutional Trading of HealthStream

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSTM. Barclays PLC boosted its stake in shares of HealthStream by 145.0% during the third quarter. Barclays PLC now owns 58,838 shares of the technology company’s stock valued at $1,697,000 after purchasing an additional 34,821 shares during the period. Robeco Institutional Asset Management B.V. boosted its position in HealthStream by 26.9% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 76,260 shares of the technology company’s stock valued at $2,425,000 after buying an additional 16,166 shares during the period. State Street Corp grew its stake in HealthStream by 1.2% in the 3rd quarter. State Street Corp now owns 974,235 shares of the technology company’s stock worth $28,097,000 after acquiring an additional 11,976 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of HealthStream by 18.7% during the third quarter. JPMorgan Chase & Co. now owns 57,204 shares of the technology company’s stock worth $1,650,000 after acquiring an additional 9,017 shares during the period. Finally, FMR LLC raised its stake in shares of HealthStream by 24.0% during the third quarter. FMR LLC now owns 119,067 shares of the technology company’s stock valued at $3,434,000 after acquiring an additional 23,055 shares in the last quarter. 69.58% of the stock is owned by hedge funds and other institutional investors.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.